The firm’s revenue from biosimilars grew 25% in the latest quarter. | Photo Credit: DHIRAJ SINGH Biocon expects a 50% drop in costs for developing complex…
Trending
- The Galaxy Watch 8 LTE model is still at a record-low price
- Tribal universities must drive innovations to improve tribal livelihoods: President Murmu
- Get to know the Sanctified Art team! — A Sanctified Art
- New Species Documented This Spring at Pine Island
- M&S’s linen-rich trousers that are ‘fabulous’ drop to £2.55 with deal
- Google Translate Prepares Practice Mode Homescreen Widget
- Jammu and Kashmir must broaden exporter base to meet 2030 target: Omar Abdullah
- 195. Can the West Reclaim its Power from Trump? (Malcolm Turnbull)
